Related Experiment Videos
Alternative splicing of IgA Fc receptor (CD89) transcripts
T J Reterink1, C L Verweij, L A van Es
1Department of Nephrology, Leiden University Hospital, The Netherlands. T.J.F.Reterink@nephrology.Medfac.LeidenUniv.nl
Gene
|October 10, 1996
Summary
An alternatively spliced CD89 transcript lacking exon 4 was found in immune cells. This altered CD89 mRNA impacts the extracellular domain, potentially affecting immune cell function.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- CD89, the Fc alpha receptor I, plays a crucial role in immune responses.
- Alternative splicing is a key mechanism for generating protein diversity.
Purpose of the Study:
- To identify and characterize alternatively spliced CD89 transcripts in human cells.
- To investigate the structural consequences of alternative splicing on the CD89 protein.
Main Methods:
- RNA extraction from peripheral blood mononuclear cells (PBMC) and U937 cells.
- RT-PCR to detect and analyze CD89 mRNA splice variants.
- Sequence analysis to identify exon skipping events.
Main Results:
- A novel alternatively spliced CD89 transcript was detected in PBMC and U937 cells.
- This transcript is characterized by the absence of exon 4, a 288-nucleotide sequence.
- The skipped exon encodes the extracellular membrane-proximal immunoglobulin-like domain (EC2).
Conclusions:
- Alternative splicing of CD89 mRNA occurs in human immune cells.
- The absence of exon 4 in the CD89 transcript results in a truncated extracellular domain.
- This structural alteration may have functional implications for CD89-mediated signaling.